Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
25
NCT01573247
Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia
Phase: Phase 1/2
Role: Lead Sponsor
Start: Dec 31, 2011
Completion: Mar 31, 2016